Page last updated: 2024-11-08

1,3,8-trihydroxy-6-hydroxymethylanthraquinone

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

1,3,8-trihydroxy-6-hydroxymethylanthraquinone: metabolite of emodin [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID361512
CHEMBL ID290932
CHEBI ID81348
SCHEMBL ID18048123
MeSH IDM0152377

Synonyms (38)

Synonym
o2h2z421ap ,
unii-o2h2z421ap
nsc624612
nsc-624612
omega-hydroxyemodin
1,3,8-trihydroxy-6-(hydroxymethyl)anthra-9,10-quinone
1,3,8-trihydroxy-6-(hydroxymethyl)anthracene-9,10-dione
.omega.-hydroxyemodin
NCGC00180600-01
ACON1_001349
ccris 1319
1,3,8-trihydroxy-6-hydroxymethylanthraquinone
9,10-anthracenedione, 1,3,8-trihydroxy-6-(hydroxymethyl)-
chebi:81348 ,
CHEMBL290932 ,
BRD-K95337480-001-01-4
481-73-2
C17810
citreorosein
1,3,8-trihydroxy-6-(hydroxymethyl)anthraquinone
hydroxyemodin, .omega.-
hydroxyemodin
anthraquinone, 1,3,8-trihydroxy-6-(hydroxymethyl)-
SCHEMBL18048123
bdbm50020376
3-(4-tert-butyl-phenoxy)-benzyl-hydrazine
AKOS028108661
1,3,8-trihydroxy-6-(hydroxymethyl)-9,10-dihydroanthracene-9,10-dione
DTXSID60197420
1,3,8-trihydroxy-6-(hydroxymethyl)-9,10-anthracenedione
w-hydroxyemodin
Q27155287
F21513
FS-9919
anthraquinone, 1,3,8-trihydroxy-6-(hydroxymethyl)-hydroxyemodin; nsc 624612; omega-hydroxyemodin
gtpl11005
anthraquinone, 1,3,8-trihydroxy-6-(hydroxymethyl)-ydroxyemodin; nsc 624612; -hydroxyemodin
AC-37073
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
trihydroxyanthraquinoneA member of the class of hydroxyanthraquinones carrying three hydroxy substituents.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (1)

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Accessory gene regulator protein AStaphylococcus aureusIC50 (µMol)8.10006.00007.05008.1000AID1155420
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (7)

Assay IDTitleYearJournalArticle
AID52626Inhibitory activity against Chymotrypsinogen at 62 uM concentration; NI = no inhibition1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID48373Inhibitory activity against Cathepsin G (CatG) at 62 uM concentration1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID67651Inhibitory activity against Porcine Pancreatic Elastase (PPE) at 62 uM concentration1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID1155421Inhibition of AGR quorum sensing system-mediated delta toxin production in methicillin-resistant Staphylococcus aureus AH2759 incubated for 15 hrs by Western blotting analysis2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry.
AID1624878Inhibition of Staphylococcus aureus USA300 LAC quorum sensing system Agr assessed as reduction in AIP production measured after 5 hrs by UPLC-MS analysis2019Journal of natural products, 03-22, Volume: 82, Issue:3
Prenylated Diresorcinols Inhibit Bacterial Quorum Sensing.
AID67320Inhibitory activity against Human Leukocyte Elastase (HLE) at 62 uM concentration1992Journal of medicinal chemistry, May-01, Volume: 35, Issue:9
Novel anthraquinone inhibitors of human leukocyte elastase and cathepsin G.
AID1155420Inhibition of AGR quorum sensing system in methicillin-resistant Staphylococcus aureus AH2759 incubated for 15 hrs by P3-LUX reporter gene assay2014Journal of natural products, Jun-27, Volume: 77, Issue:6
Polyhydroxyanthraquinones as quorum sensing inhibitors from the guttates of Penicillium restrictum and their analysis by desorption electrospray ionization mass spectrometry.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (13)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (7.69)18.7374
1990's1 (7.69)18.2507
2000's1 (7.69)29.6817
2010's10 (76.92)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 13.06

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index13.06 (24.57)
Research Supply Index2.64 (2.92)
Research Growth Index5.70 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (13.06)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other13 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]